Zenivex Features and Benefits
With three ready-to-use alternatives for aerial, ground, or hand applications, Zenivex® mosquito adulticide provides quick, permanent knockdown and reliable control of adult mosquito populations in numerous habitats. As a high efficacy, reduced-risk adulticide that provides no aquatic setbacks and has crop approval, Zenivex® products allow you to spray throughout urban and rural settings.
The active ingredient, Etofenprox, is classified by the EPA as reduced risk making Zenivex® products the ideal choice in mosquito control.
Active Ingredient Features:
- Low Odor
- Non–Ester Pyrethroid
- Unique Molecule
- Effective on Organophosphate Resistant Mosquitoes
- Sodium Channel Blocker
- Improved Safety for Operators and Bystanders
Products:
Zenivex® E4 RTU adulticide was designed to give mosquito control professionals operational options when controlling mosquitoes. It is an oil-based formulation for Ultra Low Volume (ULV) applications and does not require dilution.
Aqua Zenivex™ E20 has the efficacy and toxicity profile of Zenivex® products in a water-dilutable formulation. In addition, it is classified as a reduced-risk adulticide by the Environmental Protection Agency (EPA), making it the ideal mosquito-control option for professional adult control.
Zenivex® E20 can be sprayed over cropland, and the oil-based formulation can be used both neat and diluted for Ultra Low Volume (ULV) applications.
Zenivex® Rebate
Now you can get cashback on your adulticide purchases with the Rebate®Zenivex. Orders of Zenivex® E20 and Aqua Zenivex™ E20 totaling 90 gallons or more qualify for a 10% rebate. Orders of Zenivex® E4 RTU of 120 gallons or more qualify for a 7.5% rebate. Zenivex® E4 and Zenivex® E20 are oil-based formulations for Ultra-Low Volume (ULV) applications and do not require dilution. Aqua Zenivex™ E20 has the toxicity and efficacy profile of Zenivex® products in a water-dilutable formulation.
The Rebate®Zenivex will be valid toward qualifying purchases made from June 1, 2021, to August 31, 2021.